1.
B. Rawson NS. Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand. J Popl Ther Clin Pharmacol [Internet]. 2020 Jun. 1 [cited 2022 Oct. 1];27(2):e58-e67. Available from: https://www.jptcp.com/index.php/jptcp/article/view/673